Paper · 36934116
Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity.
Patra T and 5 others. NPJ Vaccines, 2023. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity. Papers, record 36934116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36934116
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI124429 | NIAID NIH HHS | United States | R01AI124429 | PubMed | NIH RePORTER |
| R01 DK058023 | NIDDK NIH HHS | United States | R01DK058023 | PubMed and NIH | NIH RePORTER |
| R01 DK122401 | NIDDK NIH HHS | United States | R01DK122401 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16,103,160 | Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. | J Virol | 2005 | https://conductscience.org/library/papers/16103160 | PubMed |
| 2 | 22,171,278 | Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization. | J Virol | 2012 | https://conductscience.org/library/papers/22171278 | PubMed |
| 3 | 35,612,312 | Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response. | J Virol | 2022 | https://conductscience.org/library/papers/35612312 | PubMed |
| 4 | 20,677,942 | Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins. | J Infect Dis | 2010 | https://conductscience.org/library/papers/20677942 | PubMed |
| 5 | 22,084,442 | Granzyme B regulates antiviral CD8+ T cell responses. | J Immunol | 2011 | https://conductscience.org/library/papers/22084442 | PubMed |
| 6 | 29,443,378 | Hepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages. | Hepatology | 2019 | https://conductscience.org/library/papers/29443378 | PubMed |
| 7 | 17,977,972 | Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus. | J Virol | 2008 | https://conductscience.org/library/papers/17977972 | PubMed |
| 8 | 24,583,033 | The past, present and future of neutralizing antibodies for hepatitis C virus. | Antiviral Res | 2014 | https://conductscience.org/library/papers/24583033 | PubMed |
| 9 | 25,275,133 | Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization. | J Virol | 2014 | https://conductscience.org/library/papers/25275133 | PubMed |
| 10 | 32,016,547 | Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice. | Arch Virol | 2020 | https://conductscience.org/library/papers/32016547 | PubMed |
1 to 10 of 24
See all 24 referencesCited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,827,179 | Immunopharmacological design of a multi-epitope vaccine targeting hepatitis C virus genotype 3a. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42827179 | PubMed |
| 42,514,657 | Overcoming Antigenic Drift in PEDV: Broadly Protective Antigen Design and sIgA-Driven Lactogenic Immunity. | Vet Sci | 2026 | https://conductscience.org/library/papers/42514657 | PubMed |
| 42,368,401 | Trivalent mRNA-LNP Vaccine Induces Robust Humoral and Cellular Immunity in Mice: Preclinical Evaluation for Porcine Enteric Coronaviruses. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42368401 | PubMed |
| 42,347,630 | Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347630 | PubMed |
| 42,129,447 | Deglycosylation of hepatitis C virus pseudoparticles with 2-3,6,8,9 Neuraminidase A elicits protective neutralizing antibodies in mice. | Sci Rep | 2026 | https://conductscience.org/library/papers/42129447 | PubMed |
| 41,939,904 | Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939904 | PubMed |
| 41,772,850 | Vaccines at the Heart of Hepatitis Elimination: Insights From the ESCMID Study Group for Viral Hepatitis (ESGVH). | Liver Int | 2026 | https://conductscience.org/library/papers/41772850 | PubMed |
| 41,750,254 | Targeted Removal of HCV E2 N2 N-Glycan Is Associated with Improved Immune Responses in Mice. | Biomolecules | 2026 | https://conductscience.org/library/papers/41750254 | PubMed |
| 41,649,705 | Nanoparticle approaches for hepatitis therapy and clinical translation. | Discov Nano | 2026 | https://conductscience.org/library/papers/41649705 | PubMed |
| 41,185,028 | A trimer ancestral spike-based mRNA vaccine confers cross-generational protection against SADS-CoV. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41185028 | PubMed |
1 to 10 of 27
See all 27 cited byGenes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD81 | 975 | PubTator's text mining | https://conductscience.org/library/genes/975 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| ERVK-20 | 100,616,444 | PubTator's text mining | https://conductscience.org/library/genes/100616444 | NCBI Gene |
| FUT2 | 2,524 | PubTator's text mining | https://conductscience.org/library/genes/2524 | NCBI Gene |
| GZMB | 3,002 | PubTator's text mining | https://conductscience.org/library/genes/3002 | NCBI Gene |
| IFNG | 3,458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL10 | 3,586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL2 | 3,558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL4 | 3,565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| NUSAP1 | 51,203 | PubTator's text mining | https://conductscience.org/library/genes/51203 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36934116
GET https://conductscience.org/api/papers/v1/36934116/references?page=2